Anti-tumor necrosis factor-alpha improves myocardial recovery after ischemia and reperfusion

Journal of the American College of Cardiology

Volumn 30, Issue 6, 1997, Pages 1554-1561

  Gurevitch, Jacob ^a   Frolkis, Inna ^a   Yuhas, Yael ^b   Lifschitz Mercer, Beatriz ^a   Berger, Esther ^a   Paz, Yosef ^a   Matsa, Menachem ^a   Kramer, Amir ^a   Mohr, Rephael ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOPLEGIC AGENT; CREATINE KINASE; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOPLEGIA; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE REPERFUSION; HEART PERFORMANCE; IMMUNOHISTOCHEMISTRY; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALS; ANTIBODIES, MONOCLONAL; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; ORGAN CULTURE TECHNIQUES; OXYGEN CONSUMPTION; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030689717     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00328-8     Document Type: Article

References (36)

1. Tracey KJ, Beutler B, Lowrey SF, et al. Shock and tissue injury induced by recombinant human cachectin. Science 1986;229:869-71.
2. Oliff A, Defeo-Jones D, Boyer M, et al. Tumor secreting human tumor necrosis factor-α/cachectin induce cachectia in mice. Cell 1987;50:555-63.
3. Yamada T, Matsumori A, Sasayama S. Therapeutic effect of anti-tumor necrosis factor-α antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus. Circulation 1994;89:846-51.
4. Arbustini E, Grasso M, Diegoli M, et al. Expression of tumor necrosis factor in human acute cardiac rejection: an immunohistochemical and immunoblotting study. Am J Pathol 1991;139:709-15.
5. Maury CPJ, Teppo AM. Circulating tumor necrosis factor-α (cachectin) in myocardial infarction. J Intern Med 1989;225:333-6.
6. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990;223:236-41.
7. Jansen JN, van Oeveren W, Gu YJ, van Vliet MH, Eijsman L, Wildevuur CR. Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass. Ann Thorac Surg 1992;54:744-8.
8. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A 1975;72:3666-70.
9. Caputi AP, Squadrito F. Role of tumor necrosis factor-α and therapeutic perspectives in bowel and myocardial ischaemia reperfusion injury. Pharmacol Res 1992;26 Suppl 2:150-1.
10. Lucchesi BR. Modulation of leukocyte-mediated myocardial reperfusion injury. Ann Rev Physiol 1990;52:561-76.
11. Dinerman JL, Mehta JL. Endothelial, platelet and leukocyte interactions in ischaemic heart disease: insights into potential mechanisms and their clinical relevance. J Am Coll Cardiol 1991;17:1445-6.
12. Ikeda U, Ikeda M, Kano S, Shimada K. Neutrophil adherence to rat cardiac myocyte by proinflamatory cytokines. J Cardiovasc Pharmacol 1994;23:647-52.
13. Kukielka GL, Hawkins HK, Michael L, et al. Regulation of intracellular adhesion molecule-1 (ICAM-1) in ischemic and reperfused canine myocardium. J Clin Invest 1993;92:1504-16.
14. Youker KA, Hawkins HK, Kukielka GL, et al. Molecular evidence for induction of intracellular adhesion molecule-1 (ICAM-1) in the viable border zone associated with ischemia-reperfusion injury of the dog heart. Circulation 1994;89:2736-46.
15. Squadrito F, Altavilla D, Zingarelli B, et al. Tumor necrosis factor involvement in myocardial ischaemia-reperfusion injury. Eur J Pharmacol 1993;237: 223-30.
16. Downey JM. Free radicals and their involvement during long term myocardial ischaemia and reperfusion. Ann Rev Physiol 1990;52:487-504.
17. Vane JR, Vasara H, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990;323:27-36.
18. Gurevitch J, Frolkis I, Yuhas Y, et al. Tumor necrosis factor-alpha is released from the isolated heart undergoing ischemia and reperfusion. J Am Coll Cardiol 1996;28:247-52.
19. Wallach D. Preparation of lymphotoxin induce resistance and their own cytotoxic effect. J Immunol 1984;132:2464-9.
20. Yuhas Y, Shemer I, Sarov I, Wallach D. Protection of cells from TNF-α cytotoxicity by tryptophan and indole. Eur Cytokine Netw 1990;1:35-40.
21. Sheehan KCF, Ruddle NH, Schreiber RD. Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. J Immunol 1989;142:3884-93.
22. Rabinovici R, Bugelski PJ, Esser KM, Killegas LM, Vernick J, Feuerstein G. ARDS-like lung injury produced by endotoxin in platelet-activating factor-primed rats. J Appl Physiol 1993;74:1791-802.
23. Neely JR, Liebermeister H, Battersby EJ, Morgan HE. Effects of pressure development on oxygen consumption by isolated rat hearts. Am J Physiol 1967;212:804-14.
24. Suffredini AF, Fromm RE, Parker MM, et al. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989;321: 280-7.
25. Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, Mann DL. Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian heart. J Clin Invest 1993;92:2303-12.
26. Torre-Amione G, Kapadia S, Lee J, Bies RD, Lebovitz R, Mann DL. Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation 1995;92:1487-93.
27. Giroir BP, Horton JW, White J, McIntyre KL, Lin CQ. Inhibition of tumor necrosis factor prevents myocardial dysfunction during burn shock. Am J Physiol 1994;267:H118-24.
28. Imagawa DK, Millis JM, Sue P, et al. The role of tumor necrosis factor in allograft rejection. Transplantation 1991;51:57-62.
29. Herskowitz A, Choi S, Ansari AA, Wesselingh S. Cytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol 1995;146:419-28.
30. Kapadia S, Lee J, Torre-Amione G, Birdsall HH, Ma TS, Mann DL. Tumor necrosis factor-α gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest 1995;96:1042-52.
31. Murphy HS, Shayman JA, Till GO, et al. Superoxide responses of endothelial cells to C5a and TNF: divergent signal transduction pathways. Am J Physiol 1992;263:L51-9.
32. Pogrebniak HW, Matthews WA, Pass HI. Reactive oxygen species can amplify macrophage tumor necrosis factor production. Surg Forum 1990;16: 101-3.
33. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992;257:387-9.
34. Kapadia S, Torre-Amione G, Yokoyama T, Mann DL. Soluble TNF binding proteins modulate the negative inotropic properties of TNF-α in vitro. Am J Physiol 1995;268:H517-25.
35. Torre-Amione G, Kapadia S, Lee J, et al. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation 1996;93: 704-11.
36. Munro JM, Pober JS, Cotran RS. TNF-α and IFN-γ induced distinct patterns of endothelial activation and associated leukocyte accumulation in skin of Papio anubis. Am J Pathol 1989;135:121-33.